Clinical trials

  • ALDESLEUKIN for Alzheimer disease
  • MARIDEBART CAFRAGLUTIDE for Heart failure with preserved ejection fraction (HFpEF) | Heart failure with mildly reduced ejection fraction (HFmrEF) | Obesity
  • Clenbuterol hydrochloride for Spinal and bulbar muscular atrophy
  • MARIDEBART CAFRAGLUTIDE for Atherosclerotic cardiovascular disease | Obesity
  • PIOGLITAZONE for Metabolic-associated fatty liver disease (MAFLD) | Prediabetes
  • METHYLPREDNISOLONE HYDROGEN SUCCINATE for Chronic obstructive pulmonary disease
  • PP1493 for Prosthetic joint infection (hip or knee) due to Staphylococcus aureus
  • Cabozantinib for Clear cell renal cell carcinoma | Renal cell carcinoma
  • REGORAFENIB for Rectal cancer (locally-advanced, stage II-III)
  • DOSTARLIMAB for Recurrent ovarian cancer | Recurrent fallopian tube cancer | Primary peritoneal cancer
  • ZANIDATAMAB for HER2-overexpressing solid tumors|Breast cancer|Gastric cancer|Non-small cell lung cancer|Colorectal cancer|Gastroesophageal cancer|Ovarian cancer|Endometrial cancer|Salivary gland cancer|Esophageal adenocarcinoma|Cervical cancer|Pancreatic cancer|Urothelial carcinoma
  • Clonidine hydrochloride for Persistent spinal pain syndrome type II (PSPS T2)